Marie-Françoise Avril

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.

Marie Françoise Avril;S. Aamdal;J. J. Grob;A. Hauschild.
Journal of Clinical Oncology (2004)

HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance

P Paul;N Rouas-Freiss;I Khalil-Daher;P Moreau.
Proceedings of the National Academy of Sciences of the United States of America (1998)

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

Véronique Winnepenninckx;Vladimir Lazar;Stefan Michiels;Philippe Dessen.
Journal of the National Cancer Institute (2006)

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub.
Nature (2011)

Genome-wide association study identifies three loci associated with melanoma risk.

D Timothy Bishop;Florence Demenais;Mark M Iles;Mark Harland.
Nature Genetics (2009)

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

Alisa M. Goldstein;May Chan;Mark Harland;Elizabeth M. Gillanders.
Cancer Research (2006)

Prevalence of p16 and CDK4 Germline Mutations in 48 Melanoma-Prone Families in France

Nadem Soufir;Marie-Françoise Avril;Agnès Chompret;Florence Demenais.
Human Molecular Genetics (1998)

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

Eve Maubec;Peter Petrow;Isabelle Scheer-Senyarich;Pierre Duvillard.
Journal of Clinical Oncology (2011)

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.

Jianxin Shi;Xiaohong R. Yang;Bari Ballew;Melissa Rotunno.
Nature Genetics (2014)

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases

Florent Grange;Marie Beylot-Barry;Phillipe Courville;Eve Maubec.
Archives of Dermatology (2007)